Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings

Journal of Clinical Pathology

Volumn 52, Issue 7, 1999, Pages 494-497

  Hobbs, F D Richard ^a   Fitzmaurice, David A ^a   Murray, Ellen T ^a   Holder, Roger ^a   Rose, Peter E ^b   Roper, Jacquie L ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WARWICK HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

INR testing; Primary care; Secondary care

Indexed keywords

WARFARIN;

ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; HOSPITAL LABORATORY; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NURSE; ORAL DRUG ADMINISTRATION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0032992277     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.7.494     Document Type: Article

References (17)

1. 1 Taylor F, Ramsey M, Voke J, et al. GPs not prepared for monitoring anticoagulation. BMJ 1993;307:1493.
2. 2 Sweeney KG, Pereira Gray D, Steele R, et al. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract 1995;45:153-8.
3. 3 Poller L. Advances in oral anticoagulant treatment. In: Poller L, ed. Recent advances in blood coagulation, vol 4. Edinburgh: Churchill Livingstone, 1985:191-214.
4. 4 Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41:444-7.
5. 5 Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method Coagucheck for the determination of the prothrombin time from capillary blood: comparison with Thrombotest on KC-1. Thromb Res 1995;77:563-7.
6. 6 Sanders KJ, Lewis SM, Cooper S, et al. An evaluation of the Nycomed Thrombotrak coagulation system. London: NHS Procurement Directorate, 1989.
7. 7 Fitzmaurice DA, Hobbs FDR, Murray ET, et al. Evaluation of utilizing computerised decision support system (DSS) in the therapeutic management of oral anticoagulation in general practice. Fam Pract 1995;12:505.
8. 8 Sadowski JA, Bovill EG, Mann KG. In: Poller L, ed. Recent advances in blood coagulation, vol 5. Edinburgh: Churchill Livingstone, 1991:93-118.
9. 9 Preston FE. Quality control and oral anticoagulation. Thromb Haemost 1995;74:515-20.
10. 10 Poller L, Taberner DA. Dosage and control of oral anticoagulants: an international survey. Br J Haematol 1982;51:479-85.
11. 11 Hirsh J Poller L. The international normalised ratio. A guide to understanding and correcting its problems. Arch Intern Med 1994;54:282-8.
12. 12 JCSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardisation in haematology and International Committee on Thrombosis and Haemostasis. J Clin Pathol 1985;38:133-4.
13. 13 Poller L, Thomson JM. Problems of internarional normalized ratio implementation in prothrombin time standardization. In: Poller L, ed. Recent advances in blood coagulation, vol 6. Edinburgh: Churchill Livingstone, 1993:155-68.
14. 14 British Committee For Standardisation In Haematology. Guidelines on oral anti-coagulation, 2nd ed. J Clin Pathol 1990;43:177-83.
15. 15 Eckman MH, Levine HJ, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993;329:696-701.
16. 16 Morrison M, Fitzsimons EJ. Discrepant INR values strike again. Clin Lab Haematol 1991;13:221-5.
17. 17 Morrison M, Fimls G, Caldwell A. Discrepant INR values: a comparison between Manchester and Thrombotest reagents using capillary and venous samples. Clin Lab Haematol 1989;11:393-98.